RecruitingPhase 1NCT06934382

Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Stephan Grupp MD PhD
Principal Investigator
Caroline Diorio, MD
Children's Hospital of Philadelphia
Intervention
Allogeneic anti-CD7 CAR-T cells (BEAM-201)(biological)
Enrollment
33 enrolled
Eligibility
0-29 years · All sexes
Timeline
20252031

Study locations (1)

Collaborators

Beam Therapeutics Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06934382 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials